Documentos relacionados

1. Cloxacillin-induced acute vanishing bile duct syndrome: A case study and literature review.
2. UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis.
3. Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics.
4. [Diagnosis and treatment of hereditary cholestasis].
5. EUS-guided biliary interventions for benign diseases and unsuccessful ERCP - a prospective unicenter feasibility study on a large consecutive patient cohort.
6. Use of therapeutic plasma exchange to remove lipoprotein X in a patient with vanishing bile duct syndrome presenting with cholestasis, pseudohyponatremia, and hypercholesterolemia: A case report and review of literature.
7. Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis.
8. Aseptic meningitis, hepatitis and cholestasis induced by trimethoprim/sulfamethoxazole: a case report.
9. Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support.
10. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].